CALR and essential thrombocythemia: Still, the Italian Collaborative Group for Myeloproliferative Disorders showed that when analyzing 404 patients with either ET or pre-fibrotic PMF, CALR mutations were more frequent in pre-fibrotic PMF than in ET (35·8 vs. 17·8%, P < 001).